Rapid Serum IgG Reduction Predicts Short-Term Clinical Gains in Generalized Myasthenia Gravis
A post hoc analysis of a phase III batoclimab trial reveals that rapid total serum IgG reduction serves as a ...
A post hoc analysis of a phase III batoclimab trial reveals that rapid total serum IgG reduction serves as a ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.